- With the current market cycle now in its 10th year—a decade during which growth investing has significantly outperformed value investing—discussions around a potential style inflection point have started to intensify.
- Many investors still seem to view growth and value investing in very binary terms. However, we do not believe that a clear and definitive line separating the two styles exists, nor do we feel it necessary to try and pick the inflection point.
- From finding nontraditional growth opportunities that others overlook to uncovering real value in emerging markets, the traditional domain of growth investors, there could be rewards for those who are prepared to look beyond the traditional style definitions.
In the decade since the end of the global financial crisis, growth stocks have substantially outperformed their value counterparts. However, with the postcrisis expansionary phase now in its 10th year, the prospect of an eventual slowdown grows ever nearer. Having been out of favor for much of the past decade, value stocks are attracting attention again. Are we nearing a potential inflection point in the growth/value relationship? With this in mind, we spoke to experts on each side of the divide, and spanning both developed and emerging markets, about some of the common misconceptions surrounding growth and value investing.
Q: What do you think is most misunderstood about investing in growth and value strategies?
Taymour Tamaddon: For growth investors, perhaps the biggest misconception is that all our attention is, and should be, spent on finding the most dynamic, fastest-growing, companies out there. This is obviously a large part of what we focus our
efforts on—trying to identify early those dynamic, innovative companies that we
believe are on the right side of change.
The biggest impact so far has been on small-cap companies. Around 35% of companies listed in the small-cap Russell 2000 Index are not making profits,1 and
many of those firms were heavily funded by quantitative easing (the flow of money
into biotechs has also been a factor here). If the Fed’s hikes are modest an controlled, there will be some negative impact on earnings, but it’s unlikely to
However, there are two other growth “buckets” where we also spend a great
deal of time looking for opportunities. The first of these focuses on companies where we believe the market is underestimating 2 the durability of growth. For example, we might like a company that is expected to grow at 10%–15% per annum. In this instance, we don’t necessarily think that the company is going to surprise the market and grow by 20%–25%. It is simply that we believe the potential runway for growth is much longer and more durable, than the market is anticipating. Instead of growing at 10%–15% for three or four years, we might think it can continue at this rate for 10 years.
The beauty of these durable growth companies is that, over an extended period, they can potentially deliver significant compounded returns for clients. This type of company is unlikely to be among the top performers in any single year. But, when you look back over a 5- or 10-year period, the real value creation is evident.
The third bucket in our growth framework is made up of companies that the market has effectively left for dead. That is, companies that are positioned on the
wrong side of change in our opinion but which, through either self-innovation or market changes, can find themselves on the right side. Not only can these companies subsequently grow at a faster rate, they can also experience multiple
expansion, i.e., investors willing to pay a higher price for expected increased
Ernest Yeung: I am on the other side of the discussion and, as a value investor and, more specifically, an emerging markets (EM) value investor, I believe perhaps the biggest misconception is that attractive value opportunities in the EM region are few and far between.
This is not surprising, given that EMs tend to be associated with high growth. As a result, the majority of all active money in the EM universe is invested in core and growth portfolios, while only a small percentage is value-focused.
Given this bias toward core/ growth there are many areas that are being overlooked or forgotten. This disparity between the two investment styles is perhaps the biggest disconnect between emerging and developed markets, in my view.
For example, I currently can buy what are, in my view, some of the best franchise banks and best insurance companies in emerging markets at historically low prices. Of course, the widely held perception is that financials are cheap for a reason. This might be true for developed markets (DM), where financials are struggling due to depressed 10‑year bond yields. However, there are 30 different countries in the emerging market universe. And unlike developed markets, the yield curve in some central and Eastern European countries, as well as in China, has been steepening for two years. Also, capital spending in EMs is at a 15-year low, so I expect this to pick up going forward. With increased capex comes job creation, rising wages, and loan growth. So EM financials look well positioned currently, in contrast to their developed market counterparts.
Another misconception is that the same rules apply, whether in emerging or developed markets. However, value investing in EM is very different from value investing in DM. For example, many DM value investors will focus on buying “falling star” companies, average down the cost, and then wait for some catalyst to trigger mean reversion. However, mean reversion doesn’t really happen in EMs. Cheap stocks can stay cheap for a very long time due to opaque ownership structures, weaker governance, and a prevalence of family- and state-owned companies, among other factors. There are also very few takeover stories or leveraged buyouts in EMs. So there are limited opportunities to buy genuinely cheap price-to-earnings or price‑to‑book companies and simply wait for them to pay off.
Accordingly, I tend to focus on the forgotten areas, the markets and companies that nobody else is looking at. For example, little is heard about the Middle East as a constructive place to invest. In fact, the Middle East has outperformed broader emerging markets considerably in 2018, supported by a high dividend yield and the current strength of oil prices.
South Africa is another forgotten country that nobody really talks about. Even the local entrepreneurs tend to take any profits they make andinvest them outside South Africa. However, the country is home to some good‑quality companies, so this is another market we like.
Yoram Lustig: Rather than a particular side, I take a more holistic view of the growth/value landscape, in the context of potential sources of return. In the multi-asset space, when we construct a solution we want to have exposure to as many potential sources of return as possible, including growth and value and large- and small-cap investments. The first way that we try to create returns for investors is through the blend of these exposures. In terms of value and growth, we try to keep a healthy balance between the two asit can be challenging to predict when one is going to outperform the other.
The second way we can help investors is via tactical asset allocation, i.e., dynamically allocating between asset classes and assets to generate alpha. Here, we have an Asset Allocation Committee that formulates views about whether value or growth is likely to outperform. However, we do not need to predict an inflection point between the two styles. Instead, if we can see that the cycle of growth or value is building, we simply lean into that cycle, adding value through tactical asset allocation.
Finally, disciplined portfolio rebalancing is important. It makes sense to rebalance a portfolio regularly to maintain a healthy profit-taking discipline. Over the past decade, for example, you would periodically take some profits from the outperforming growth exposure and buy value. This might seem counterintuitive, given value’s ongoing underperformance; however, you are buying the value stocks that our portfolio managers have chosen— quality companies that they expect to do well over the long term. In effect, you are taking profits from past winners and buying expected future winners.
This might seem counterintuitive, given value’s ongoing underperformance; however, you are buying the value stocks that our portfolio managers have chosen— quality companies that they expect to do well over the long term. In effect, you are taking profits from past winners and buying expected future winners.
Q. Where to next? Will growth continue to lead, or is value ready to shine?
Taymour Tamaddon: From a growth perspective, one of the potential influences that I focus on is inflation expectations. Historically, a relatively low, stable inflation environment has seen growth investing do very well. This is the environment we are currently in and that is expected in the near term, but I am always looking for any changes in the outlook. So I am also very focused on interest rates. The Federal Reserve currently faces conflicting concerns, namely, which poses the greater risk: keeping interest rates low or raising them? For me, I think the bigger risk would be to raise interest rates too quickly, so I think the Fed will be very watchful going forward. Finally, I am constantly watching for any early signs of recession. Historically, value has significantly outperformed growth during recessionary periods. One of the obvious
signals of heightened risk seems to be when a misallocation of capital is evident, i.e., market bubbles. So far, I don’t see any obvious large pockets of misallocated capital.
Ernest Yeung: As an EM value investor, I also need to consider the potential impact of a peak in the U.S. economy. EM and U.S. stock markets currently have a correlation of around 0.75. So if the U.S. economy rolls over, EM will not be immune to the slowdown. However, even in the event of such a headwind developing, we would simply buckle down and work even harder to find companies with the potential to improve and outperform in a tougher market environment. A crucial point to remember is that, for investors in the EM value space, the luxury of valuation multiples at very low levels remains.
Yoram Lustig: To try and answer this question, it is important to try and understand why growth has outperformed value so strongly over the past decade. In developed markets, this has obviously been driven by the growth in technology stocks in recent
years. However, this could change. If a global trade war develops, for example, the technology sector would be one area to suffer. High valuations could also be
a stumbling block for the technology sector. Meanwhile, on the value side, financials stand to benefit if the U.S. yield curve suddenly steepens.
Growth investing has also benefited from low interest rates over the past decade. If you think about growth investments, they have a long duration because their cash flows are further into the future. In contrast, value stocks tend to pay high dividends today, so a rising rate environment will not be as supportive for growth investing going forward. Finally, the economy will also play a part. Value stocks tend to perform well when there is an economic slowdown, and at some point, we will see a slowdown.
Key Risks—The following risks are materially relevant to the strategies highlighted in this material: Transactions in securities of foreign currencies may be subject to fluctuations of exchange rates which may affect the value of an investment. The strategies are subject to the volatility inherent in equity investing, and the value may fluctuate more than portfolios investing in income-oriented securities. In emerging markets, returns can be more volatile than other, more developed, markets due to changes in market, political and economic conditions. There is increased risk where there is the ability to employ both growth and value approaches in pursuit of long-term capital appreciation.
This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up.
Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
It is not intended for distribution to retail investors in any jurisdiction.
USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.
© 2018 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.